Catalyst Wire Dossier Catalyst Wire Dossier

CIN-103

· CinPhloro Pharma, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CIN-103, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). [Phase 2]

See pricing